HHS Doubles Monkeypox Vaccine Order, Increases Testing Capacity

Published on July 15, 2022

In a move akin to a superhero doubling down on their powers, the U.S. Department of Health and Human Services has bolstered its defenses against monkeypox. They have just increased their order of Bavarian Nordic’s Jynneos monkeypox vaccine by a staggering 2.5 million doses. This influx of additional vaccines shows a clear commitment to keeping monkeypox at bay and protecting public health. Furthermore, the agency is not stopping there. Alongside this vaccine boost, the HHS is also ramping up testing capacity for monkeypox. By expanding their testing capabilities, they will be able to quickly diagnose and contain any potential monkeypox outbreaks, effectively acting as sentinels in defense against the virus. With this proactive approach, HHS aims to ensure the safety and well-being of the nation. Fans of this vital research can read more about it on the external news source.

The U.S. Department of Health and Human Services doubled its order of Bavarian Nordic’s Jynneos monkeypox vaccine by another 2.5 million doses Friday, the agency announced.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>